In this issue
Research
Substandard and falsified medicines: global and local efforts to address a growing problemSubscription
Substandard and falsified medicines pose a risk to public health all around the world.
Insight
‘One-size-fits-all’ treatment targets harm frail older patients with diabetesSubscription
HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.
CPD article
Stevens–Johnson syndrome and toxic epidermal necrolysisSubscription
Practical guidelines for the treatment and management of Stevens–Johnson syndrome and toxic epidermal necrolysis, rare but life-threatening conditions that are normally caused by drugs or infections.
Short communications
Piloting an undergraduate student-led health check serviceSubscription
There is a growing focus on the development of communication and clinical skills during undergraduate pharmacy programmes; this has been demonstrated particularly by the General Pharmaceutical Council’s recent consultation on initial education and training
Reducing cephalosporin-related supply errorsSubscription
Cephalosporins are a class of beta-lactam antimicrobials that exert bactericidal effects through disruption of the bacterial cell wall. These broad-spectrum antimicrobials have played a core role in the treatment of severe infections since their launch in the latter half of the 20th century. Early generation cephalosporins provide robust coverage of Gram-positive bacteria, while the newer third- and fourth-generations offer additional Gram-negative coverage, including Pseudomonas ...
